Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06501443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06501443 · ClinicalTrials.gov record · last posted 2025-12-30

LATAM LOWERS LDL-C

StatusRecruiting
PhasePhase 4
Started2025-02-11
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is an open label, patient-level 1:1 randomized clinical trial in a multi-country study aiming to evaluate the real-world impact of inclisiran + Usual Care (UC) vs UC alone on LDL-C lowering, patient-reported outcomes, and healthcare resource utilization in an in-hospital population of patients, admitted during the acute setting, stabilized and before discharge, following an acute cardiovascular event.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2024-07-08; most recent amendment 2025-12-22. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-03-11
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT06501443
Lead Sponsor Novartis Pharmaceuticals
Conditions Hypercholesterolaemia
Enrollment 520 participants
Start Date 2025-02-11
Primary Completion 2026-11-27 (estimated)
Study Completion 2026-11-29 (estimated)
Updated on ClinicalTrials.gov 2025-12-30